CARDIOVASCULAR RISK AND ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS AND OBSERVATIONAL STUDIES (METADTCR)

被引:0
|
作者
Scailteux, L. -M. [1 ]
Naudet, F. [1 ]
Alimi, Q. [1 ]
Vincendeau, S. [1 ]
Oger, E. [1 ]
机构
[1] Rennes Univ Hosp, Rennes, France
关键词
D O I
10.1016/j.clinthera.2015.05.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:E3 / E3
页数:1
相关论文
共 50 条
  • [21] Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis
    Hinojosa-Gonzalez, David E.
    Zafar, Affan
    Saffati, Gal
    Kronstedt, Shane
    Zlatev, Dimitar V.
    Khera, Mohit
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (03) : 507 - 519
  • [22] Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials
    Jones, Craig
    Gray, Struan
    Brown, Michael
    Brown, Janet
    Mccloskey, Eugene
    Rai, Bhavan P.
    Clarke, Noel
    Sachdeva, Ashwin
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (05): : 993 - 1004
  • [23] Risk of Fracture During Androgen Deprivation Therapy Among Patients With Prostate Cancer: A Systematic Review and Meta-Analysis of Cohort Studies
    Wu, Cheng Chih
    Chen, Po Yen
    Wang, Shih Wei
    Tsai, Meng Hsuan
    Wang, Yu Chin Lily
    Tai, Ching Ling
    Luo, Hao Lun
    Wang, Hung-Jen
    Chen, Chung Yu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Androgen deprivation therapy use and the risk of heart failure in patients with prostate cancer: a systematic review and meta-analysis
    Khorram, Amir Alinejad
    Pourasgharian, Reyhaneh
    Shams, Ali Samadi
    Toufani, Shahin
    Mostafaei, Mehrsa
    Khademi, Reza
    Daghayeghi, Reza
    Valifard, Maryam
    Shahrokhi, Mehregan
    Seyedipour, Sina
    Deravi, Niloofar
    Naziri, Mahdyieh
    Malek, Mahta
    Bashir, Faizan
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [25] Cardiovascular effects of androgen receptor signalling inhibitors in the treatment of advanced and metastatic prostate cancer: A systematic review and meta-analysis of randomised controlled trials
    El-Taji, O.
    Jones, C.
    Brown, M. D.
    Clarke, N. W.
    Sachdeva, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S986 - S986
  • [26] Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer A Meta-analysis of Randomized Trials
    Nguyen, Paul L.
    Je, Youjin
    Schutz, Fabio A. B.
    Hoffman, Karen E.
    Hu, Jim C.
    Parekh, Arti
    Beckman, Joshua A.
    Choueiri, Toni K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (21): : 2359 - 2366
  • [27] Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies
    Loke, Yoon K.
    Cavallazzi, Rodrigo
    Singh, Sonal
    THORAX, 2011, 66 (08) : 699 - 708
  • [28] Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
    Serpa Neto, A.
    Tobias-Machado, M.
    Esteves, M. A. P.
    Senra, M. D.
    Wroclawski, M. L.
    Fonseca, F. L. A.
    dos Reis, R. B.
    Pompeo, A. C. L.
    Giglio, A. D.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (01) : 36 - 44
  • [29] Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: A systematic review and meta-analysis
    Wroclawski, M. L.
    Serpa Neto, A.
    Tobias-Machado, M.
    Esteves, M. A.
    Fonseca, F. L.
    Senra, M. D.
    Pompeo, A. C.
    Del Giglio, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
    A Serpa Neto
    M Tobias-Machado
    M A P Esteves
    M D Senra
    M L Wroclawski
    F L A Fonseca
    R B dos Reis
    A C L Pompeo
    A D Giglio
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 36 - 44